Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−99.92 M USD
0.00 USD
16.10 M
About enGene Holdings Inc.
Sector
Industry
CEO
Ronald H. W. Cooper
Website
Headquarters
Saint-Laurent
Founded
2023
FIGI
BBG01J1GCYW7
enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ENGN is 7.68 USD — it has increased by 0.13% in the past 24 hours. Watch enGene Holdings Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange enGene Holdings Inc. stocks are traded under the ticker ENGN.
ENGN stock has fallen by −4.00% compared to the previous week, the month change is a −16.43% fall, over the last year enGene Holdings Inc. has showed a 0.72% increase.
We've gathered analysts' opinions on enGene Holdings Inc. future price: according to them, ENGN price has a max estimate of 40.00 USD and a min estimate of 16.00 USD. Watch ENGN chart and read a more detailed enGene Holdings Inc. stock forecast: see what analysts think of enGene Holdings Inc. and suggest that you do with its stocks.
ENGN reached its all-time high on Apr 30, 2013 with the price of 52.84 USD, and its all-time low was 4.42 USD and was reached on Sep 26, 2024. View more price dynamics on ENGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ENGN stock is 4.44% volatile and has beta coefficient of 0.07. Track enGene Holdings Inc. stock price on the chart and check out the list of the most volatile stocks — is enGene Holdings Inc. there?
Today enGene Holdings Inc. has the market capitalization of 339.58 M, it has increased by 0.52% over the last week.
Yes, you can track enGene Holdings Inc. financials in yearly and quarterly reports right on TradingView.
enGene Holdings Inc. is going to release the next earnings report on Feb 3, 2025. Keep track of upcoming events with our Earnings Calendar.
ENGN earnings for the last quarter are −0.32 USD per share, whereas the estimation was −0.38 USD resulting in a 14.73% surprise. The estimated earnings for the next quarter are −0.41 USD per share. See more details about enGene Holdings Inc. earnings.
enGene Holdings Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ENGN net income for the last quarter is −14.15 M USD, while the quarter before that showed −14.98 M USD of net income which accounts for 5.58% change. Track more enGene Holdings Inc. financial stats to get the full picture.
No, ENGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 33.00 employees. See our rating of the largest employees — is enGene Holdings Inc. on this list?
Like other stocks, ENGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade enGene Holdings Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So enGene Holdings Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating enGene Holdings Inc. stock shows the sell signal. See more of enGene Holdings Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.